Guidelines for the treatment of autoimmune neuromuscular transmission disorders.
Important progress has been made in our understanding of the cellular and molecular processes underlying the autoimmune neuromuscular transmission (NMT) disorders; myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS) and neuromyotonia (peripheral nerve hyperexcitability; Isaacs syndrome)...
主要な著者: | Skeie, G, Apostolski, S, Evoli, A, Gilhus, N, Hart, I, Harms, L, Hilton-Jones, D, Melms, A, Verschuuren, J, Horge, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2006
|
類似資料
-
Guidelines for treatment of autoimmune neuromuscular transmission disorders.
著者:: Skeie, G, 等
出版事項: (2010) -
Autoimmune Neuromuscular Transmission Disorders
著者:: Skeie, G, 等
出版事項: (2010) -
Disorders of Neuromuscular Transmission
著者:: Vincent, A, 等
出版事項: (2011) -
Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.
著者:: Vincent, A, 等
出版事項: (2000) -
Autoimmune disorders of the neuromuscular junction.
著者:: Vincent, A
出版事項: (2008)